Скачать или смотреть Ferritin acts as a robust biomarker for patient prognosis

Erman Akkus, MD, Ankara University Medical School, Ankara, Turkey, highlights the link between serum ferritin levels and survival outcomes in advanced biliary tract cancer. Despite treatment advances, reliable biomarkers are still lacking to determine patient suitability for treatment regimes. His findings support serum ferritin as a strong prognostic biomarker, as elevated levels correlate with shorter progression-free and overall survival. This interview took place at the European Society for Medical Oncology (ESMO) Gastrointestinal Cancer 2025 Congress in Barcelona, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.